Research graph
References from Non-invasive assessment of hepatic steatosis in Wilson Disease: An international registry-based study. Local targets link to admitted publications; unresolved targets remain external evidence.
The Prevalence of Wilson’s Disease: An Update
10.1002/hep.30911 · 2020 · External reference
A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases
10.1002/hep.32801 · 2025 · External reference
High Copper Selectively Alters Lipid Metabolism and Cell Cycle Machinery in the Mouse Model of Wilson Disease
10.1074/jbc.m607496200 · 2007 · External reference
Wilson disease: histopathological correlations with treatment on follow-up liver biopsies
10.3748/wjg.v16.i12.1487 · 2010 · External reference
Liver pathology in Wilson’s disease: From copper overload to cirrhosis
10.1016/j.jinorgbio.2019.01.008 · 2019 · External reference
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
10.1016/j.jhep.2023.06.003 · 2023 · External reference
Metabolic dysfunction–associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease
10.1097/hep.0000000000000670 · 2024 · External reference
Steatotic liver disease
10.1016/s0140-6736(24)01811-7 · 2024 · External reference
Review article: Hepatic steatosis and its associations with acute and chronic liver diseases
10.1111/apt.18059 · 2024 · External reference
Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study
10.1002/hep.32635 · 2023 · External reference
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
10.1016/j.jhep.2016.12.022 · 2017 · External reference
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
10.1016/j.eclinm.2022.101547 · 2022 · External reference
Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
2023 · External reference
Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B
10.5604/16652681.1171762 · 2015 · External reference
Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease
10.1016/j.dld.2009.08.002 · 2010 · External reference
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
10.5009/gnl19301 · 2021 · External reference
10.1016/j.jhep.2024.04.031
10.1016/j.jhep.2024.04.031 · 2024 · External reference
Hepatic steatosis in Wilson disease - Role of copper and PNPLA3 mutations
10.1016/j.jhep.2015.01.034 · 2015 · External reference
Predictive value of liver enzymes in long-term prognosis of hepatic Wilson disease: results from the Wilson AEEH registry
10.1186/s13023-025-03821-1 · 2025 · External reference
Application of attenuation coefficient in the assessment of hepatic involvement in children and adolescents with Wilson’s disease
10.1186/s12880-023-00979-7 · 2023 · External reference
Assessment of liver involvement in Wilson’s disease with different liver echo patterns based on liver stiffness evaluated on Transient elastography and Sound Touch Viscoelastography
2025 · External reference
Quantitative MR in Paediatric Patients with Wilson Disease: A Case Series Review
2022 · External reference
Juvenile Wilson disease: histologic and functional studies during penicillamine therapy
10.1016/s0022-3476(75)80131-4 · 1975 · External reference
Treatment of Wilson’s disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study
10.1016/j.lab.2005.01.007 · 2005 · External reference
